Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

SQI Diagnostics Inc. (V:SQD)

Business Focus: Advanced Medical Equipment & Technology

Get the company report for the most recent outlook updated daily
Log in or join to add this stock to your watch list.

Insider Chart - Past 6 Months

Insider Filings

Latest 10 SEDI filings for SQD within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Aug 20, 2019 14:37 ET
SQI Diagnostics to Announce Third Quarter 2019 Results
TORONTO, Aug. 20, 2019 /CNW/ - SQI Diagnostics Inc. ("SQI Diagnostics" or the "Company") (TSX-V: SQD; OTCQB: SQIDF), today announced that it plans to release its financial and operational results for the three and nine months ended June 30, 2019, at 8:00 a.m. EDT Wednesday, August 28, 2019.  President and CEO, Andrew Morris, along with Company management, will host a conference call on Wednesday, August 28, 2019, at 10:00 a.m. EDT to review financial results and discuss business developments for the period. 
Read full article
Aug 20, 2019 14:37 ET
SQI Diagnostics to Announce Third Quarter 2019 Results
TORONTO, Aug. 20, 2019 /PRNewswire/ - SQI Diagnostics Inc. ("SQI Diagnostics" or the "Company") (TSX-V: SQD; OTCQB: SQIDF), today announced that it plans to release its financial and operational results for the three and nine months ended June 30, 2019, at 8:00 a.m. EDT Wednesday, August 28, 2019.  President and CEO, Andrew Morris, along with Company management, will host a conference call on Wednesday, August 28, 2019, at 10:00 a.m. EDT to review financial results and discuss business developments for the period.  ...
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
1.70
--
--
Price to Sales - TTM
12.05
13.66
13.45
Price to Book - most recent quarter
15.01
4.23
2.78
Price to Cash Flow per share - TTM
--
34.61
12.38
Price to Free Cash Flow per share - TTM
--
11.05
14.95
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Jul 31, 20195,471-714
Jul 15, 20196,185-2,098
Jun 30, 20198,283-114,307
See Short Report

Business Summary

Sector:  Healthcare Industry:  Advanced Medical Equipment & Technology

SQI Diagnostics Inc (SQI) is a Canada-based diagnostics company. The Company develops multiplexed tests and automated systems for customers needing to measure a range of biomarkers in blood or other common sample types. It offers three different platforms sqidlite, sqid x and the siqdworks to run and analyze its microarray plates. Its Ig_plex microarrays have the ability to discriminate between individual isotypes of antibodies and antigens and proteins within a single well of a microarray. Its Ig_plex CHEX technology provides multiple in-microarray checks. It has three areas of focus: Testing for the drug development industry, Animal health testing, Human disease testing or deoxyribonucleic acid (DNA) diagnostic testing. In drug development testing, SQI provides technology and equipment for blood testing in clinical trials and pre-clinical research for developing various drugs. It applies its multiplexing technology to diagnostic tests used for customers in the animal health segment.

See business summary

Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).

Twitter

Search (past week) for $SQD.CA SQD.V